MOF ACTION - bccancer.bc.ca MECHANISM OF ACTION: Sunitinib inhibits the phosphorylation of multiple receptor
tyrosine kinases (RTKs).2 It is a potent inhibitor of platelet- derived growth
factor receptors (PDGFRα and PDGFRβ), vascular endothelial growth factor ... Related articles - View as HTML - All 2 versions